Impact of ablation of Barrett’s esophagus with low-grade dysplasia on patients’ illness perception and quality of life: a multicenter randomized trial

Background and Aims A previous multicenter randomized trial demonstrated that radiofrequency ablation (RFA) significantly reduced the risk of neoplastic progression compared with surveillance (1.5% vs 26.5%) in patients with Barrett’s esophagus (BE) and low-grade dysplasia (LGD). In the same population, this study aimed to compare the quality of life (QOL) and illness perception (IP) among patients treated with RFA and patients kept under...